Optimization Lumbar Puncture In Children (OLPIC)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- children with indications of lumbar puncture;
- voluntarily signed the informed consent
Exclusion Criteria:
- topical anesthetic skin allergies;
- skin infection in lumbar puncture site;
- severe intracranial hypertension;
- unstable vital signs;
- coagulopathy;
- intracranial hemorrhage and occupying;
- low back pain;
- headache and low back pain before lumbar puncture;
- past headache after lumbar puncture;
- mental retardation, neuropsychiatric symptoms;
- children could not immediately act after the lumbar puncture(such as disturbance of consciousness or suffering from underlying diseases or drainage);
- the case with repeated puncture in one operation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Group 1
no anesthesia; postoperative management
|
lying without the pillow for half an hour after lumbar puncture
|
|
No Intervention: Group 2
no anesthesia; lying without the pillow and fasting water and food for four hours after lumbar puncture
|
|
|
Experimental: Group 3
surface anesthesia with lidocaine; postoperative management
|
lying without the pillow for half an hour after lumbar puncture
surface anesthesia with lidocaine
|
|
Experimental: Group 4
surface anesthesia with lidocaine; lying without the pillow and fasting water and food for four hours after lumbar puncture
|
surface anesthesia with lidocaine
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of participants with Postoperation complications include headache, backache, vomit, cerebral hernia, allergy
Time Frame: up to five days postoperation
|
up to five days postoperation
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
degree of adaptability
Time Frame: intraoperative
|
evaluated by the FLACC(The face,legs,activity,cry,consolability behavioral tool) scale
|
intraoperative
|
|
time of lumbar puncture
Time Frame: intraoperative
|
intraoperative
|
|
|
number of puncture
Time Frame: intraoperative
|
intraoperative
|
|
|
success rate
Time Frame: intraoperative
|
intraoperative
|
|
|
whether bad memories exist or not
Time Frame: up to four hours postoperation
|
A questionaire about the operation for all parents and children will be investigated.
|
up to four hours postoperation
|
|
Composite measure of Vital signs include heart rate, pulse, blood pressure and respiration.
Time Frame: up to four hours postoperation
|
up to four hours postoperation
|
|
|
comfort degree
Time Frame: up to four hours postoperation
|
evaluated by the FLACC(The face,legs,activity,cry,consolability behavioral tool) scale
|
up to four hours postoperation
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Wounds and Injuries
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
Other Study ID Numbers
Other Study ID Numbers
- 20150206
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.